NEWS

Cromos™ Pharma received regulatory approval for the first ever ophthalmological clinical trial in Georgia Tbilisi, Georgia. February 21, 2017. On February 17, 2017 the State Regulation Agency for Medical Activities, Ministry of Labour, Health and Social Affairs of Georgia granted Cromos™ Pharma approval to conduct the very first ophthalmology trial in Georgia. This international Phase III study in patients with Dry Eye Disease will enroll patients at 3 specialized

Cromos Pharma has published a white paper that gives a comprehensive overview of clinical trial landscape in the Republic of Georgia, which is becoming a very attractive location for clinical trials

DUBLIN, IRELAND–(Marketwired – October 24, 2016) – Cromos™ Pharma, a premier regional contract research organization announced today that Dr. Gearóid Tuohy has been appointed…

We at Cromos Pharma are always interested in what makes a sponsor choose a certain CRO In order to get a better understanding of this question we have conducted a survey where we asked industry professionals about their vision of a “perfect CRO”. Our team would like to express sincere gratitude to all the participants of the survey whose responses we greatly appreciate. Below you can find the top-line results of

Cromos Pharma published a new article on Feasibilty in Applied Clinical Trials Journal We are delighted to announce that Applied Clinical Trials, the leading journal in its field has published our article that addresses the key issues facing the sponsor when choosing international clinical trial locations -‎ Feasibility in the Age of International Clinical Trials‎ by Vlad Bogin, MD, FACP We hope that you find the article informative

Cromos™ Pharma opens a representative office in Hungary